...
首页> 外文期刊>Hybridoma >Generation of Monoclonal Antibodies Against Human Recombinant Interferon Beta Using Genetic Immunization with Simultaneous Expression of IgM and IgG Isotypes
【24h】

Generation of Monoclonal Antibodies Against Human Recombinant Interferon Beta Using Genetic Immunization with Simultaneous Expression of IgM and IgG Isotypes

机译:使用基因免疫同时表达IgM和IgG同种型的人类重组干扰素β单克隆抗体的产生。

获取原文
获取原文并翻译 | 示例
           

摘要

Monoclonal antibodies (MAbs) against human recombinant interferon β (hrIFNβ) were generated by genetic immunization (GI). In order to test two viral promoters frequently used in mammalian expression plasmid vectors, mice were inoculated four times by intramuscular injection, without adjuvant, with 100μg of either pcDNA 3.1hrIFNβ or pZeoSV2IFNβ containing the entire human interferon β gene and under the control of, respectively, human cytomegalovirus (HCMV) immediate-early promoter or early SV-40 enhancer/promoter. Only serum samples from mice immunized with pZeoSV2IFNβ were positive to anti-hrIFNβ. The spleens of the immunized mice were fused with myeloma Sp2/0 cells and the hybridoma clones generated screened by an in house enzyme-linked immunosorbent assay (ELISA). Fourteen MAbs were selected as reactive with hrIFNβ. Western blot analysis was performed and only one recognized the 18kDa isoform (non-glycosylated) of hrIFNβ. All MAbs were subjected to antibody isotype characterization with a commercial ELISA and showed unusual profile with simultaneous expression of both IgM and IgG2a isotypes. This observation is further supported by RT-PCR amplification of the IgM CH4 domain using total RNA from hybridomas.
机译:通过基因免疫(GI)产生了针对人类重组干扰素β(hrIFNβ)的单克隆抗体(MAb)。为了测试两个常用在哺乳动物表达质粒载体中的病毒启动子,分别在无佐剂的情况下通过肌内注射将100μg含有完整人干扰素β基因的pcDNA3.1hrIFNβ或pZeoSV2IFNβ接种小鼠四次,并分别在其控制下进行接种。 ,人类巨细胞病毒(HCMV)立即早期启动子或早期SV-40增强子/启动子。仅来自用pZeoSV2IFNβ免疫的小鼠的血清样品对抗hrIFNβ呈阳性。将免疫小鼠的脾脏与骨髓瘤Sp2 / 0细胞融合,并通过室内酶联免疫吸附测定(ELISA)筛选产生的杂交瘤克隆。选择十四个MAb与hrIFNβ反应。进行了蛋白质印迹分析,并且仅一个人识别了hrIFNβ的18kDa同工型(非糖基化)。所有的单克隆抗体都通过商业ELISA进行了抗体同种型鉴定,并显示出不同寻常的特征,同时表达IgM和IgG2a同种型。使用杂交瘤中的总RNA对IgM CH4域进行RT-PCR扩增,进一步支持了这一观察结果。

著录项

  • 来源
    《Hybridoma》 |2009年第3期|211-214|共4页
  • 作者单位

    Post-graduate Office of Master Course in Molecular and Cellular Biology (Professional Master Course of Technologies in Immunobiology), Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.;

    Laboratory of Recombinant Technology, Bio-Manguinhos, Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil.;

    Laboratory of Recombinant Technology, Bio-Manguinhos, Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil.;

    Laboratory of Recombinant Technology, Bio-Manguinhos, Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil.;

    Laboratory of Recombinant Technology, Bio-Manguinhos, Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil.;

    Laboratory of Monoclonal Antibodies Technology, BioManguinhos, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.;

    Laboratory of Recombinant Technology, Bio-Manguinhos, Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil.;

    Laboratory of Recombinant Technology, Bio-Manguinhos, Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil.;

    Biopharmaceuticals Program, Bio-Manguinhos, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.;

    Vice-directory of Technological Development, Bio-Manguinhos, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.;

    Laboratory of Recombinant Technology, Bio-Manguinhos, Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil.;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号